OVERVIEW

Improving Clinical and Cost Outcomes in Pulmonary Arterial Hypertension: Incorporating Newer Treatments and Pharmacoeconomic Data to Benefit Design is organized by North American Center for Continuing Medical Education (NACCME) and would be held during Sep 30, 2016 - Sep 30, 2017.

The target audience for this medical event are pharmacy directors, medical directors, and other health plan decision makers whose patient population includes individuals infected with PAH. This CME conference has been approved with a maximum of 1 AMA PRA Category 1 Credit.

Learning Objectives
After completing this actvity, participants should be able to:
• Describe the clinical and economic consequences of delayed diagnosis, suboptimal treatment, and hospitalizations in PAH
• Support diagnostic and treatment protocols for patients with PAH using evidence-based guidelines and recent clinical data
• Evaluate the impact of new PAH treatments and combination strategies on plan medical/pharmacy spend and benefit design
• Apply recent clinical/cost data, current treatment guidelines, and individualized care strategies to formulary and plan management discussions

SPECIALITIES

Cardiology

RELATED ONLINE COURSES

Webcast

Emergency Medicine
More actions
US$200

Webcast

Pediatrics
28 AMA PRA Category 1 Credits™
More actions
US$910